focus -WSS

focus

author：fashion 2025-10-01 21:27:10 Page View：95666

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： There should be a 'Moonshot' or 'Warp Speed' for rare diseases
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

Cholera vaccine supplies dangerously low, outbreaks surging

AhealthworkerholdsasampleofcholeravaccineinHarare,Zimbabwe.JEKESAINJIKIZANA/AFPviaGettyImagesAnunpre

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Why you shouldn’t ask, “What country has the best health care?”

AdobeI’vespentmycareerstudyinghowdifferenthealthcaresystemswork.Peoplelovetoaskmewhichcountryhastheb

focus

explore

leisure time

Why you shouldn’t ask, “What country has the best health care?”